Unicorn Brief: 23andMe

Home/Unicorn Brief/Unicorn Brief: 23andMe

Unicorn Brief: 23andMe

23andMe was Granted the First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk

Here’s how they are currently tracking against the Prime Unicorn Index:

 

About the Author:

Business Intelligence Analyst

Leave A Comment